- Report
- February 2024
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
From €3177EUR$3,500USD£2,737GBP
- Report
- November 2023
- 90 Pages
Germany
From €3177EUR$3,500USD£2,737GBP
- Report
- November 2023
- 149 Pages
Asia Pacific
From €3631EUR$4,000USD£3,128GBP
- Report
- November 2023
- 120 Pages
Europe
From €3631EUR$4,000USD£3,128GBP
- Report
- October 2023
- 126 Pages
North America
From €3631EUR$4,000USD£3,128GBP
- Report
- August 2023
- 78 Pages
Egypt
From €3177EUR$3,500USD£2,737GBP
- Report
- August 2023
- 76 Pages
South Korea
From €3177EUR$3,500USD£2,737GBP
- Report
- December 2022
- 72 Pages
Israel
From €3177EUR$3,500USD£2,737GBP
- Report
- October 2023
- 43 Pages
Global
From €4039EUR$4,450USD£3,480GBP
- Report
- December 2020
Global
From €5446EUR$6,000USD£4,692GBP
- Report
- February 2024
- 172 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- May 2024
- 336 Pages
Global
From €4539EUR$5,000USD£3,910GBP
- Report
- May 2025
- 315 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- March 2025
- 282 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- February 2025
- 262 Pages
Global
From €4539EUR$5,000USD£3,910GBP
- Report
- September 2024
- 353 Pages
Global
From €4539EUR$5,000USD£3,910GBP
- Report
- May 2024
- 296 Pages
Global
From €4539EUR$5,000USD£3,910GBP
- Report
- May 2024
- 313 Pages
Global
From €4539EUR$5,000USD£3,910GBP
- Report
- January 2024
- 262 Pages
Global
From €4539EUR$5,000USD£3,910GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more